Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
African Sleeping Sickness (ASS)
Transcript of African Sleeping Sickness (ASS)
What is it?
Protozoan parasitic disese
Associated with Tsetse fly bite
Endemic to sub-Saharan Africa
30,000 est. infected
~70 million at 'very high' risk
4 major outbreaks since 1890's (2008)
Routes of exposure
Tsetse fly (Glossina) bite
vector for trypansome
parasites "injects" trypomastigotes into skin where they enter lymphatic system then onto the bloodstream
From here the trypomastigotes move to other areas of the body.
Replication during this time: binary fission.
Other routes of infection
the bug can cross the placental barrier
[Possible] sexual contact
Obligate protozoan parasite
carried by an insect vector - mammalian host
humans though to be reservoir host
3 sub species
in 95% of cases
Causes slow onset of chronic Trypanosomiasis
humans will have red sore, fever, swollen lymph glands.
Can affect domestic pets (horses, dogs, etc).
Have a specialized coat (VSG) which undergo antigenic variation allowing for host immunity evasion
haemolymphatic (first stage)
headaches, fever, joint pain
insomina, mode changes, weakness, inflamed bite
neurological (second stage)
disruption of sleep cycle
New (2013) research on preventing disease fatality.
Symptoms and Diagnosis
Robinson, Victor, Ph.C., M.D. (editor) (1939). "African Lethargy, Sleeping Sickness, or Congo trypanosomiasis; Trypanosoma gambiense". The Modern Home Physician, A New Encyclopedia of Medical Knowledge. WM. H. Wise & Company (New York)., pp. 20–21.
MedlinePlus Encyclopedia Sleeping sickness
WHO Media centre (2012). Fact sheet N°259: Trypanosomiasis, Human African (sleeping sickness).
Simarro PP, Cecchi G, Franco JR, Paone M, Diarra A, Ruiz-Postigo JA, Fèvre EM, Mattioli RC, Jannin JG (2012). "Estimating and Mapping the Population at Risk of Sleeping Sickness". PLoS Negl Trop Dis 6 (10)
"New treatments raise hope of cutting sleeping sickness deaths". The Guardian. May 15, 2009.
"Uganda: Sleeping Sickness Reaching Alarming Levels," New Vision, May 11, 2008.
Medlock 2013, p. e2374
GB Lundkvist, K Kristensson, M Bentivoglio (2004). "Why Trypanosomes Cause Sleeping Sickness". Physiology19: 198–206. doi:10.1152/physiol.00006.2004.
Brun R, Blum J, Chappuis F, Burri C (2010). "Human African trypanosomiasis".
Dr Charlie Easmon, “Sleeping sickness overview” http://www.netdoctor.co.uk/travel/diseases/sleeping_sickness.htm 18.09.2013
The insect vector for T. brucei is the tsetse fly (genus Glossina). The initial site of infection is the midgut of the fly (procyclic life cycle stage) and as the infection progresses it migrates via the proventriculus to the salivary glands where it attaches to the salivary gland surface (linked with a differentiation into the epimastigote life cycle stage). In the salivary glands some parasites detach and undergo adaptations (differentiation into the metacyclic life cycle stage) in preparation for injection to the mammalian host with the fly saliva on biting. In the mammal host the parasite lives within the bloodstream (slender bloodstream life cycle stage). Some parasites undergo adaptations (differentiation into the stumpy bloodstream life cycle stage) where it can reinfect the fly vector as it takes a blood meal after biting. In later stages of a T. brucei infection of a mammalian host the parasite may migrate from the bloodstream to also infect the lymph and cerebrospinal fluids.
T. brucei gambiense : slow onset - chronic trypanosomiasis
T. brucei rhodensiense : fast - acute (more severe)
T. brucei brucei : cause African Trypanosomiasis.
All carried by insect vectors and lead to meningoencephalitis
Cerebrospinal fluid test
IgM and possible IgG elevation
Was first use as topical for women
Injection became popular in the 2008 epidemic
Fromerly melarsoprol but many adverse effects (arsenic)
Intravenous melarsoprol (12 days)
can be combined with oral nifurtimox
can relapse without mlarsoprol
or eflornithine (14 days)
Sodalis glossinidius is a Gram-negative, nonspore-forming, rod-shaped, filamentous bacteria.
"S. glossinidius is ... possibly enabling the creation of tsetse flies that are incapable of transimtting trypanosomes and thus controlling the spread of African sleeping sickness"
high variable N terminal domain (350 amino acids)
allows for persistent evasion of host adaptive immunity
allows for chronic infection to persist
prevents host immune system from accessing plasma membrane
full-length intact genes vs pseudoenes and often frameshift mutations to allow for gene alteration.
often switched on or changed.